Presence of Chlamydia Trachomatis and Mycoplasma Spp., but Not
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Phagocytosis of Borrelia Burgdorferi, the Lyme Disease Spirochete, Potentiates Innate Immune Activation and Induces Apoptosis in Human Monocytes Adriana R
University of Connecticut OpenCommons@UConn UCHC Articles - Research University of Connecticut Health Center Research 1-2008 Phagocytosis of Borrelia burgdorferi, the Lyme Disease Spirochete, Potentiates Innate Immune Activation and Induces Apoptosis in Human Monocytes Adriana R. Cruz University of Connecticut School of Medicine and Dentistry Meagan W. Moore University of Connecticut School of Medicine and Dentistry Carson J. La Vake University of Connecticut School of Medicine and Dentistry Christian H. Eggers University of Connecticut School of Medicine and Dentistry Juan C. Salazar University of Connecticut School of Medicine and Dentistry See next page for additional authors Follow this and additional works at: https://opencommons.uconn.edu/uchcres_articles Part of the Medicine and Health Sciences Commons Recommended Citation Cruz, Adriana R.; Moore, Meagan W.; La Vake, Carson J.; Eggers, Christian H.; Salazar, Juan C.; and Radolf, Justin D., "Phagocytosis of Borrelia burgdorferi, the Lyme Disease Spirochete, Potentiates Innate Immune Activation and Induces Apoptosis in Human Monocytes" (2008). UCHC Articles - Research. 182. https://opencommons.uconn.edu/uchcres_articles/182 Authors Adriana R. Cruz, Meagan W. Moore, Carson J. La Vake, Christian H. Eggers, Juan C. Salazar, and Justin D. Radolf This article is available at OpenCommons@UConn: https://opencommons.uconn.edu/uchcres_articles/182 INFECTION AND IMMUNITY, Jan. 2008, p. 56–70 Vol. 76, No. 1 0019-9567/08/$08.00ϩ0 doi:10.1128/IAI.01039-07 Copyright © 2008, American Society for Microbiology. All Rights Reserved. Phagocytosis of Borrelia burgdorferi, the Lyme Disease Spirochete, Potentiates Innate Immune Activation and Induces Apoptosis in Human Monocytesᰔ Adriana R. Cruz,1†‡ Meagan W. Moore,1† Carson J. -
Borrelia Burgdorferi and Treponema Pallidum: a Comparison of Functional Genomics, Environmental Adaptations, and Pathogenic Mechanisms
PERSPECTIVE SERIES Bacterial polymorphisms Martin J. Blaser and James M. Musser, Series Editors Borrelia burgdorferi and Treponema pallidum: a comparison of functional genomics, environmental adaptations, and pathogenic mechanisms Stephen F. Porcella and Tom G. Schwan Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, Montana, USA Address correspondence to: Tom G. Schwan, Rocky Mountain Laboratories, 903 South 4th Street, Hamilton, Montana 59840, USA. Phone: (406) 363-9250; Fax: (406) 363-9445; E-mail: [email protected]. Spirochetes are a diverse group of bacteria found in (6–8). Here, we compare the biology and genomes of soil, deep in marine sediments, commensal in the gut these two spirochetal pathogens with reference to their of termites and other arthropods, or obligate parasites different host associations and modes of transmission. of vertebrates. Two pathogenic spirochetes that are the focus of this perspective are Borrelia burgdorferi sensu Genomic structure lato, a causative agent of Lyme disease, and Treponema A striking difference between B. burgdorferi and T. pal- pallidum subspecies pallidum, the agent of venereal lidum is their total genomic structure. Although both syphilis. Although these organisms are bound togeth- pathogens have small genomes, compared with many er by ancient ancestry and similar morphology (Figure well known bacteria such as Escherichia coli and Mycobac- 1), as well as by the protean nature of the infections terium tuberculosis, the genomic structure of B. burgdorferi they cause, many differences exist in their life cycles, environmental adaptations, and impact on human health and behavior. The specific mechanisms con- tributing to multisystem disease and persistent, long- term infections caused by both organisms in spite of significant immune responses are not yet understood. -
Treponema Pallidum, the Syphilis Spirochete: Making a Living As a Stealth Pathogen
HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Nat Rev Manuscript Author Microbiol. Author Manuscript Author manuscript; available in PMC 2017 June 01. Published in final edited form as: Nat Rev Microbiol. 2016 December ; 14(12): 744–759. doi:10.1038/nrmicro.2016.141. Treponema pallidum, the syphilis spirochete: making a living as a stealth pathogen Justin D. Radolf1, Ranjit K. Deka2, Arvind Anand3, David Šmajs4, Michael V. Norgard5, and X. Frank Yang6 1Departments of Medicine, Pediatrics, Genetics and Genomic Science, Molecular Biology and Biophysics, and Immunology, UConn Health, Farmington, CT, USA 2Department of Microbiology, The University of Texas Southwestern Medical Center, Dallas, TX, USA 3Department of Medicine, UConn Health, Farmington, CT, USA 4Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic 5Department of Microbiology, The University of Texas Southwestern Medical Center, Dallas, TX, USA 6Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN Abstract The last two decades have seen a worldwide resurgence in infections caused by Treponema pallidum subsp. pallidum, the syphilis spirochete. The syphilis spirochete’s well-recognized capacity for early dissemination and immune evasion has earned it the designation ‘the stealth pathogen’. Despite the many hurdles to studying syphilis pathogenesis, most notably the inability to culture and to genetically manipulate T. pallidum, in recent years, considerable progress has been made in elucidating the structural, physiologic, and regulatory facets of stealth pathogenicity. In this Review, we integrate this eclectic body of information to garner fresh insights into the highly successful parasitic lifestyles of the syphilis spirochete and related pathogenic treponemes. Pathogenic treponemes cause venereal syphilis, yaws, endemic syphilis, and pinta—multi- stage, infections that, although similar, can be differentiated based on clinical, epidemiologic, and geographic criteria1,2. -
WHO GUIDELINES for the Treatment of Treponema Pallidum (Syphilis)
WHO GUIDELINES FOR THE Treatment of Treponema pallidum (syphilis) WHO GUIDELINES FOR THE Treatment of Treponema pallidum (syphilis) WHO Library Cataloguing-in-Publication Data WHO guidelines for the treatment of Treponema pallidum (syphilis). Contents: Web annex D: Evidence profiles and evidence-to-decision frameworks - Web annex E: Systematic reviews for syphilis guidelines - Web annex F: Summary of conflicts of interest 1.Syphilis – drug therapy. 2.Treponema pallidum. 3.Sexually Transmitted Diseases. 4.Guideline. I.World Health Organization. ISBN 978 92 4 154980 6 (NLM classification: WC 170) © World Health Organization 2016 All rights reserved. Publications of the World Health Organization are available on the WHO website (http://www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO website (http://www.who.int/about/licensing/ copyright_form/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. -
Morphology of Spirochaeta Myelophthora in Multiple Sclerosis
MORPHOLOGY OF SPIROCHAETA MYELOPHTHORA IN MULTIPLE SCLEROSIS GABRIEL STEINER, M.D. (Detroit, Mich.) In a recent paper (1) the findings of specific spirochetes in the brain of a newly examined subacute case of multiple sclerosis were reported and evaluated. The purpose of the present paper is to give a detailed description of these spiro chetes, their classification, their reproduction, and disintegration. Four cases of multiple sclerosis, including the case to be reported, elicited abundant numbers of specific spirochetes in the central nervous system to war rant the publication of this paper. Downloaded from 1. Further Evidence of Spirochetal Nature: It has been said that the reported spirochetes represent only spirochete-like structures of the tissue proper, such as reticulin fibrils, neurofibrils, or axis cylinders.* To disprove these objections the following experiments were done: Sections from brains of general paresis containing numerous spirochetes in the cortex and those from lungs in congenital syphilis were stained with my silver technique II (1), then desilverized with potassium permanganate and oxalic acid (A. J. Wilson (2)), http://jnen.oxfordjournals.org/ and restained for reticulin fibers (Wilder's method). They showed clearly the complete absence of spirochetes in these restained sections, at regions where many spirochetes were formerly seen. Reticulin fibrils were easily demonstrable. Such sections could be desilverized again and restained for spirochetes with positive results. In sections stained for axis cylin ders (Bielschowsky's axis cylinder method for paraffin sections), no spirochetes were seen in places where previously masses of treponemas were present. Desilverizing and restaining with technique II brought the spirochetes out again. -
Laboratory Diagnostic Testing for Treponema Pallidum
Laboratory Diagnostic Testing for Treponema pallidum Expert Consultation Meeting Summary Report January 13‐15, 2009 Atlanta, GA This report was produced in cooperation with the Centers for Disease Control and Prevention. Laboratory Diagnostic Testing for Treponema pallidum Expert Consultation Meeting Summary Report January 13‐15, 2009 Atlanta, GA In the last decade there have been major changes and improvements in STD testing technologies. While these changes have created great opportunities for more rapid and accurate STD diagnosis, they may also create confusion when laboratories attempt to incorporate new technologies into the existing structure of their laboratory. With this in mind, the Centers for Disease Control and Prevention (CDC) and the Association of Public Health Laboratories (APHL) convened an expert panel to evaluate available information and produce recommendations for inclusion in the Guidelines for the Laboratory Diagnosis of Treponema pallidum in the United States. An in‐person meeting to formulate these recommendations was held on January 13‐15, 2009 on the CDC Roybal campus. The panel included public health laboratorians, STD researchers, STD clinicians, STD Program Directors and other STD program staff. Representatives from the Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) were also in attendance. The target audience for these recommendations includes laboratory directors, laboratory staff, microbiologists, clinicians, epidemiologists, and disease control personnel. For several months prior to the in‐person consultation, these workgroups developed key questions and researched the current literature to ensure that any recommendations made were relevant and evidence based. Published studies compiled in Tables of Evidence provided a framework for group discussion addressing several key questions. -
Prevotella Intermedia
The principles of identification of oral anaerobic pathogens Dr. Edit Urbán © by author Department of Clinical Microbiology, Faculty of Medicine ESCMID Online University of Lecture Szeged, Hungary Library Oral Microbiological Ecology Portrait of Antonie van Leeuwenhoek (1632–1723) by Jan Verkolje Leeuwenhook in 1683-realized, that the film accumulated on the surface of the teeth contained diverse structural elements: bacteria Several hundred of different© bacteria,by author fungi and protozoans can live in the oral cavity When these organisms adhere to some surface they form an organizedESCMID mass called Online dental plaque Lecture or biofilm Library © by author ESCMID Online Lecture Library Gram-negative anaerobes Non-motile rods: Motile rods: Bacteriodaceae Selenomonas Prevotella Wolinella/Campylobacter Porphyromonas Treponema Bacteroides Mitsuokella Cocci: Veillonella Fusobacterium Leptotrichia © byCapnophyles: author Haemophilus A. actinomycetemcomitans ESCMID Online C. hominis, Lecture Eikenella Library Capnocytophaga Gram-positive anaerobes Rods: Cocci: Actinomyces Stomatococcus Propionibacterium Gemella Lactobacillus Peptostreptococcus Bifidobacterium Eubacterium Clostridium © by author Facultative: Streptococcus Rothia dentocariosa Micrococcus ESCMIDCorynebacterium Online LectureStaphylococcus Library © by author ESCMID Online Lecture Library Microbiology of periodontal disease The periodontium consist of gingiva, periodontial ligament, root cementerum and alveolar bone Bacteria cause virtually all forms of inflammatory -
Chlamydia Trachomatis Neisseria Gonorrhoeae
st 21 Expert Committee on Selection and Use of Essential Medicines STI ANTIBIOTICS REVIEW (1) Have all important studies/evidence of which you are aware been included in the application? YES (2) For each of the STIs reviewed in the application, and noting the corresponding updated WHO treatment guidelines, please comment in the table below on the application’s proposal for antibiotics to be included on the EML STI ANTIBIOTICS USED IN WHO AND RECOGNIZED GUIDELINES Chlamydia trachomatis UNCOMPLICATED GENITAL CHLAMYDIA AZITHROMYCIN 1g DOXYCYCLINE 100mg TETRACYCLINE 500mg ERYTHROMYCIN 500mg OFLOXACIN 200mg ANORECTAL CHLAMYDIAL INFECTION DOXYCYCLINE 100mg AZITHROMYCIN 1g GENITAL CHLAMYDIAL INFECTION IN PREGNANT WOMEN AZITHROMYCIN 1g AMOXYCILLIN 500mg ERYTHROMYCIN 500mg LYMPHOGRANULOMA VENEREUM (LGV) DOXYCYCLINE 100mg AZITHROMYCIN 1g OPHTHALMIA NEONATORUM AZITHROMYCIN SUSPENSION ERYTHROMYCIN SUSPENSIONS FOR OCULAR PROPHYLAXIS TETRACYCLINE HYDROCHLORIDE 1% EYE OINTMENT ERYTHROMYCIN 0.5% EYE OINTMENT POVIDONE IODINE 2.5% SOLUTION (water-based) SILVER NITRATE 1% SOLUTION CHLORAMPHENICOL 1% EYE OINTMENT. Neisseria gonorrhoeae GENITAL AND ANORECTAL GONOCOCCAL INFECTIONS CEFTRIAXONE 250 MG IM + AZITHROMYCIN 1g CEFIXIME 400 MG + AZITHROMYCIN 1g SPECTINOMYCIN 2 G IM ou CEFTRIAXONE 250 MG IM ou CEFIXIME 400 MG OROPHARYNGEAL GONOCOCCAL INFECTIONS CEFTRIAXONE 250 MG IM + AZITHROMYCIN 1g CEFIXIME 400 MG + AZITHROMYCIN 1g CEFTRIAXONE 250 MG IM RETREATMENT IN CASE OF FAILURE CEFTRIAXONE 500 mg IM + AZITHROMYCIN 2g CEFIXIME 800 mg + AZITHROMYCIN 2g SPECTINOMYCIN 2 G IM + AZITHROMYCIN 2g GENTAMICIN 240 MG IM + AZITHROMYCIN 2g OPHTALMIA NEONATORUM CEFTRIAXONE 50 MG/KG IM (MAXIMUM 150 MG) KANAMYCIN 25 MG/KG IM (MAXIMUM 75 MG) SPECTINOMYCIN 25 MG/KG IM (MAXIMUM 75 MG) FOR OCULAR PROPHYLAXIS, TETRACYCLINE HYDROCHLORIDE 1% EYE OINTMENT ERYTHROMYCIN 0.5% EYE OINTMENT POVIDONE IODINE 2.5% SOLUTION (water-based) SILVER NITRATE 1% SOLUTION CHLORAMPHENICOL 1% EYE OINTMENT. -
UNIVERSITY of CALIFORNIA the Role of United States Public Health Service in the Control of Syphilis During the Early 20Th Centu
UNIVERSITY OF CALIFORNIA Los Angeles The Role of United States Public Health Service in the Control of Syphilis during the Early 20th Century A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Public Health by George Sarka 2013 ABSTRACT OF THE DISSERTATION The Role of United States Public Health Service in the Control of Syphilis during the Early 20th Century by George Sarka Doctor of Public Health University of California, Los Angeles, 2013 Professor Paul Torrens, Chair Statement of the Problem: To historians, the word syphilis usually evokes images of a bygone era where lapses in moral turpitude led to venereal disease and its eventual sequelae of medical and moral stigmata. It is considered by many, a disease of the past and simply another point of interest in the timeline of medical, military or public health history. However, the relationship of syphilis to the United States Public Health Service is more than just a fleeting moment in time. In fact, the control of syphilis in the United States during the early 20th century remains relatively unknown to most individuals including historians, medical professionals and public health specialists. This dissertation will explore following question: What was the role of the United States Public Health Service in the control of syphilis during the first half of the 20th century? This era was a fertile period to study the control of syphilis due to a plethora of factors including the following: epidemic proportions in the U.S. population and military with syphilis; the ii emergence of tools to define, recognize and treat syphilis; the occurrence of two world wars with a rise in the incidence and prevalence of syphilis, the economic ramifications of the disease; and the emergence of the U.S. -
Typical Presentation of Stress Associated Vincent Angina – a Case Report
Scholarly Journal of Otolaryngology DOI: 10.32474/SJO.2020.04.000190 ISSN: 2641-1709 Case Report Typical Presentation of Stress Associated Vincent Angina – A Case Report Richa S Gautam, Akhil K Padmanabhan*, Esha Yadav and Prabhuji MLV Department of Periodontology, Krishnadevaraya College of Dental Sciences and Hospital, India *Corresponding author: Akhil K Padmanabhan, Department of Periodontology, Krishnadevaraya College of Dental Sciences and Hospital, India Received: June 11, 2020 Published: June 24, 2020 Abstract Necrotizing periodontal diseases are the most severe rapidly destructive, non-communicable, periodontal infection of complex tissues, including gingiva, periodontal ligament, and alveolar bone. The pathognomonic clinical characteristics are the typical punchedetiology. Theout appearance,diagnosis is basedinterproximal on clinical craters and radiologicaland spontaneous features. bleeding. Necrotizing The predisposing periodontal factorslesions include are confined host factors, to periodontal such as psychological stress, immunosuppression, a smoking habit, and poor oral hygiene. If it is left untreated, it may spread laterally and apically to involve the entire gingival complex. In this case report, we presented a 24- year old male with necrotizing gingivitis and no systemic disease with a history of intense stress. The case report describes the clinical diagnosis of Necrotizing ulcerative periodontitisKeywords: Necrotizing(NUP) and its periodontal therapeutic disease; management Diagnosis; by conservative Treatment oral -
Porphyromonas Gingivalis and Treponema Denticola Exhibit Metabolic Symbioses
Porphyromonas gingivalis and Treponema denticola Exhibit Metabolic Symbioses Kheng H. Tan1., Christine A. Seers1., Stuart G. Dashper1., Helen L. Mitchell1, James S. Pyke1, Vincent Meuric1, Nada Slakeski1, Steven M. Cleal1, Jenny L. Chambers2, Malcolm J. McConville2, Eric C. Reynolds1* 1 Oral Health CRC, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Parkville, Victoria, Australia, 2 Department of Biochemistry and Molecular Biology, Bio21 Institute, The University of Melbourne, Parkville, Victoria, Australia Abstract Porphyromonas gingivalis and Treponema denticola are strongly associated with chronic periodontitis. These bacteria have been co-localized in subgingival plaque and demonstrated to exhibit symbiosis in growth in vitro and synergistic virulence upon co-infection in animal models of disease. Here we show that during continuous co-culture a P. gingivalis:T. denticola cell ratio of 6:1 was maintained with a respective increase of 54% and 30% in cell numbers when compared with mono- culture. Co-culture caused significant changes in global gene expression in both species with altered expression of 184 T. denticola and 134 P. gingivalis genes. P. gingivalis genes encoding a predicted thiamine biosynthesis pathway were up- regulated whilst genes involved in fatty acid biosynthesis were down-regulated. T. denticola genes encoding virulence factors including dentilisin and glycine catabolic pathways were significantly up-regulated during co-culture. Metabolic labeling using 13C-glycine showed that T. denticola rapidly metabolized this amino acid resulting in the production of acetate and lactate. P. gingivalis may be an important source of free glycine for T. denticola as mono-cultures of P. gingivalis and T. denticola were found to produce and consume free glycine, respectively; free glycine production by P. -
Chlamydia, Syphilis & Gonorrhea
Chlamydia, Syphilis & Gonorrhea Leaders: Faisal Al Rashed & Eman Al-Shahrani Done By: Faisal Al Rashed, Sama Al Ohali • Important | • Mentioned By doctor | • Team Notes | • Very Important The Genus Chlamydia is divided into 3 species: C.trachomatis, C.psittaci, and C.pneumoniae. C.trachomatos infections cause diseases of the genitourinary tract and the eye, including trachoma, which is a major cause of blindness. C.psittaci and C.pneumoniae infect various levels of the respiratory tract. C.trachomatis is divided into a number of serotypes, which correlate with the clinical syndrome they cause A-C, D-K, and L1-3. Chlamydia have no peptidoglycan or mumaric acid in its cell wall therefore, it can not be stained with gram stain, nor can be treated with B-lactams. β-Lactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. Chlamydiae possesses ribosomes and synthesize their own proteins and, therefore, are sensitive to antibiotics that inhibit this process, such as tetracycline (Doxycycline) and macrolides (Azithromycin, Erythromycin) they are all protein synthesis inhibitors. Pathogenesis: chlamydiae have a unique life cycle, with morphologically distinct infectious and reproductive forms. The extracellular infectious form, the elementary body, can survive extracellular cell-to-cell passage. Once it is inside the host cell, the particle reorganizes into a reticulate body, which become metabolically active and divides repeatedly within the cytoplasm of the host cell. As they divide, the reticulate bodies form an inclusion body. After that, multiplication stops and all the reticulates become new infectious elementary bodies. They are then released from the cell, ending in host cell death.